Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Aug 2016 for Sagent Pharmaceuticals, Inc., €184k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Allan Oberman: trading record in brief
Allan Oberman is a declared insider of Sagent Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 3 August 2015 to 29 August 2016.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 31 August 2016 with a transaction (€184k) in Sagent Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Allan Oberman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
9,459 shares@ US$21.758.9% of flowCommon StockSEC:0000899243-16-028314:0
92,527 shares@ US$21.7587.1% of flowCommon StockSEC:0000899243-16-028314:1
4,271 shares@ US$21.744.0% of flowCommon StockSEC:0001562180-16-002911:0
51,335 shares0Common StockSEC:0001562180-16-001775:0
54,922 shares0Common StockSEC:0001209191-15-083006:0
5 of 5 declarations
